PROLOR BIOTECH, INC. Research and Development Expense (Excluding Acquired in Process Cost)
PROLOR BIOTECH, INC. reported Research and Development Expense (Excluding Acquired in Process Cost) of $48.35 million for the 91-month period ending 2012-12-31, per its 10-K filed 2013-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost · last filed 2013-03-15
- PROLOR BIOTECH, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2012-12-31 was $26.19M, a 36.71% increase year-over-year.
- PROLOR BIOTECH, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2012-09-30 was -$4.73M.
- PROLOR BIOTECH, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2012-06-30 was $2.13M, a 10.55% decline year-over-year.
- PROLOR BIOTECH, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2012-03-31 was $4.30M, a 41.80% increase year-over-year.
- PROLOR BIOTECH, INC. research and development expense (excluding acquired in process cost) for fiscal 2012 was $15.03M, a 29.36% increase from fiscal 2011.
- PROLOR BIOTECH, INC. research and development expense (excluding acquired in process cost) for fiscal 2011 was $11.62M, a 118.67% increase from fiscal 2010.
- PROLOR BIOTECH, INC. research and development expense (excluding acquired in process cost) for fiscal 2010 was $5.31M, a 4.33% decline from fiscal 2009.
- PROLOR BIOTECH, INC. research and development expense (excluding acquired in process cost) for fiscal 2009 was $5.56M.
| Period end | Research and Development Expense (Excluding Acquired in Process Cost) 3 month | Research and Development Expense (Excluding Acquired in Process Cost) 3 month as first filed | Research and Development Expense (Excluding Acquired in Process Cost) 6 month | Research and Development Expense (Excluding Acquired in Process Cost) 9 month | Research and Development Expense (Excluding Acquired in Process Cost) 9 month as first filed | Research and Development Expense (Excluding Acquired in Process Cost) 12 month | Research and Development Expense (Excluding Acquired in Process Cost) 12 month as first filed | Research and Development Expense (Excluding Acquired in Process Cost) 73 month | Research and Development Expense (Excluding Acquired in Process Cost) 76 month | Research and Development Expense (Excluding Acquired in Process Cost) 79 month | Research and Development Expense (Excluding Acquired in Process Cost) 82 month | Research and Development Expense (Excluding Acquired in Process Cost) 85 month | Research and Development Expense (Excluding Acquired in Process Cost) 88 month | Research and Development Expense (Excluding Acquired in Process Cost) 91 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-12-31 | $26.19M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $21.46M derived: sum of 2 quarters · filed 2013-03-15 | $23.59M derived: sum of 3 quarters · filed 2013-03-15 | $15.03M 10-K · filed 2013-03-15 | $48.35M 10-K · filed 2013-03-15 | |||||||||
| 2012-09-30 | -$4.73M 10-Q · filed 2012-11-08 | -$2.60M derived: sum of 2 quarters · filed 2012-11-08 | -$11.16M 10-Q · filed 2012-11-08 | $20.86M derived: sum of 4 quarters · filed 2013-03-15 | -$40.90M 10-Q · filed 2012-11-08 | |||||||||
| 2012-06-30 | $2.13M 10-Q · filed 2012-08-09 | $6.43M 10-Q · filed 2012-08-09 | $25.59M derived: sum of 3 quarters · filed 2013-03-15 | $23.46M derived: sum of 4 quarters · filed 2013-03-15 | $36.17M 10-Q · filed 2012-08-09 | |||||||||
| 2012-03-31 | $4.30M 10-Q · filed 2012-05-04 | $23.46M derived: sum of 2 quarters · filed 2013-03-15 | $21.34M derived: sum of 3 quarters · filed 2013-03-15 | $23.72M derived: sum of 4 quarters · filed 2013-03-15 | $34.05M 10-Q · filed 2012-05-04 | |||||||||
| 2011-12-31 | $19.16M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $17.03M derived: sum of 2 quarters · filed 2013-03-15 | $19.41M derived: sum of 3 quarters · filed 2013-03-15 | $11.62M 10-K · filed 2013-03-15 | $11.42M 10-K · filed 2012-03-15 | $29.74M 10-K/A · filed 2012-03-23 | ||||||||
| 2011-09-30 | -$2.13M 10-Q · filed 2012-11-08 | $2.13M 10-Q · filed 2011-11-09 | $250.90K derived: sum of 2 quarters · filed 2012-11-08 | -$7.54M 10-Q · filed 2012-11-08 | $7.54M 10-Q · filed 2011-11-09 | $5.64M derived: sum of 4 quarters · filed 2013-03-15 | $25.86M 10-Q · filed 2011-11-09 | |||||||
| 2011-06-30 | $2.38M 10-Q · filed 2012-08-09 | $5.41M 10-Q · filed 2012-08-09 | $7.77M derived: sum of 3 quarters · filed 2013-03-15 | $8.88M derived: sum of 4 quarters · filed 2013-03-15 | $23.73M 10-Q · filed 2011-08-09 | |||||||||
| 2011-03-31 | $3.04M 10-Q · filed 2012-05-04 | $5.39M derived: sum of 2 quarters · filed 2013-03-15 | $6.50M derived: sum of 3 quarters · filed 2013-03-15 | $7.35M derived: sum of 4 quarters · filed 2013-03-15 | ||||||||||
| 2010-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $3.47M derived: sum of 2 quarters · filed 2013-03-15 | $4.31M derived: sum of 3 quarters · filed 2013-03-15 | $5.31M 10-K · filed 2013-03-15 | $5.22M 10-K · filed 2012-03-15 | |||||||||
| 2010-09-30 | $1.11M 10-Q · filed 2011-11-09 | $1.96M derived: sum of 2 quarters · filed 2011-11-09 | $2.96M 10-Q · filed 2011-11-09 | |||||||||||
| 2010-06-30 | $845.32K 10-Q · filed 2011-08-09 | $1.85M 10-Q · filed 2011-08-09 | ||||||||||||
| 2009-12-31 | $5.56M 10-K/A · filed 2012-03-23 |